0 329

Cited 81 times in

PET/CT imaging correlates with treatment outcome in patients with multidrug-resistant tuberculosis.

Authors
 Ray Y. Chen  ;  Lori E. Dodd  ;  Myungsun Lee  ;  Praveen Paripati  ;  Dima A. Hammoud  ;  James M. Mountz  ;  Doosoo Jeon  ;  Nadeem Zia  ;  Homeira Zahiri  ;  M. Teresa Coleman  ;  Matthew W. Carroll  ;  Jong Doo Lee  ;  Yeon Joo Jeong  ;  Peter Herscovitch  ;  Saher Lahouar  ;  Michael Tartakovsky  ;  Alexander Rosenthal  ;  Sandeep Somaiyya  ;  Soyoung Lee  ;  Lisa C. Goldfeder  ;  Ying Cai  ;  Laura E. Via  ;  Seung Kyu Park  ;  Sang Nae Cho  ;  Clifton E. Barry III 
Citation
 SCIENCE TRANSLATIONAL MEDICINE, Vol.6(265) : 265-166, 2014 
Journal Title
SCIENCE TRANSLATIONAL MEDICINE
ISSN
 1946-6234 
Issue Date
2014
MeSH
Adult ; Algorithms ; Double-Blind Method ; Female ; Fluorodeoxyglucose F18 ; Humans ; Lung/diagnostic imaging ; Male ; Metronidazole/therapeutic use ; Multimodal Imaging ; Observer Variation ; Positron-Emission Tomography* ; Prospective Studies ; ROC Curve ; Radiographic Image Interpretation, Computer-Assisted ; Sensitivity and Specificity ; Software ; Sputum/microbiology ; Tomography, X-Ray Computed* ; Treatment Outcome ; Tuberculosis, Multidrug-Resistant/diagnostic imaging* ; Tuberculosis, Multidrug-Resistant/therapy*
Abstract
Definitive clinical trials of new chemotherapies for treating tuberculosis (TB) require following subjects until at least 6 months after treatment discontinuation to assess for durable cure, making these trials expensive and lengthy. Surrogate endpoints relating to treatment failure and relapse are currently limited to sputum microbiology, which has limited sensitivity and specificity. We prospectively assessed radiographic changes using 2-deoxy-2-[(18)F]-fluoro-D-glucose (FDG) positron emission tomography/computed tomography (PET/CT) at 2 and 6 months (CT only) in a cohort of subjects with multidrug-resistant TB, who were treated with second-line TB therapy for 2 years and then followed for an additional 6 months. CT scans were read semiquantitatively by radiologists and were computationally evaluated using custom software to provide volumetric assessment of TB-associated abnormalities. CT scans at 6 months (but not 2 months) assessed by radiologist readers were predictive of outcomes, and changes in computed abnormal volumes were predictive of drug response at both time points. Quantitative changes in FDG uptake 2 months after starting treatment were associated with long-term outcomes. In this cohort, some radiologic markers were more sensitive than conventional sputum microbiology in distinguishing successful from unsuccessful treatment. These results support the potential of imaging scans as possible surrogate endpoints in clinical trials of new TB drug regimens. Larger cohorts confirming these results are needed.
Full Text
http://stm.sciencemag.org/content/6/265/265ra166
DOI
10.1126/scitranslmed.3009501
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Microbiology (미생물학교실) > 1. Journal Papers
1. College of Medicine (의과대학) > Dept. of Nuclear Medicine (핵의학교실) > 1. Journal Papers
Yonsei Authors
Lee, Jong Doo(이종두)
Cho, Sang Nae(조상래)
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/138720
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links